Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients.

International journal of molecular sciences - 2 Dec 2023

Zavarykina Tatiana M, Lomskova Polina K, Pronina Irina V, Khokhlova Svetlana V, Stenina Marina B, Sukhikh Gennady T

Abstract excerpt

This paper introduces the reader to the field of liquid biopsies and cell-free nucleic acids, focusing on circulating tumor DNA (ctDNA) in breast cancer (BC). BC is the most common type of cancer in women, and progress with regard to treatment has been made in recent years. Despite this, there remain a number of unresolved issues in the treatment of BC; in particular, early detection and diagnosis, reliable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell-Free Nucleic Acids

Share to Circulating Tumor DNA

Share to Liquid Biopsy

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 38069396
DOI: 10.3390/ijms242317073
PMCID: PMC10706922

Provenance

PubMed metadata and Literature Corpus relationships.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients.PMID 38069396Read ↗

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring.Semantic proximity Read ↗

Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision MedicineSemantic proximity Read ↗

Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives?Semantic proximity Read ↗

The applications of plasma cell-free DNA in cancer detection: Implications in the management of breast cancer patients.Semantic proximity Read ↗

Cell‐free circulating tumour DNA as a liquid biopsy in breast cancerSemantic proximity Read ↗

Circulating Tumor DNA in Breast Cancer: Current and Future Applications.Semantic proximity Read ↗

Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA: It Is in the Blood.Semantic proximity Read ↗

Clinical application of circulating tumor DNA in breast cancer.Semantic proximity Read ↗

Clinical applications of circulating tumor DNA in monitoring breast cancer drug resistance.Semantic proximity Read ↗

Circulating DNA as biomarker in breast cancer.Semantic proximity Read ↗

Toward liquid biopsies in cancer treatment: application of circulating tumor DNASemantic proximity Read ↗

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.